Company Name : Macro Group Pharmaceuticals -Macro Capital ISIN Code : EGS7D971C011 Reuters Code : MCRO.CA Content : The Listing Committee held on 17/03/2026 decided to address the company to abide by the provisions of Article 31 of the Listing Rules and Article 45 of the executive regulations. the Committee granted the company a one-week grace period from the date of notification of the Committee?s decision to provide the EGX with the minutes of the Extraordinary General Assembly meeting, in accordance with the provisions of Article 31 of the Listing Rules and Article 45 of executive regulations.